Arber T, Ruffion A, Terrier J-E, Paparel P, Morel Journel N, Champetier D, Dominique I
Service d'urologie du Pr. Ruffion, centre hospitalier Lyon sud, 165, chemin du grand Revoyet, 69310 Pierre-Benite, France.
Prog Urol. 2019 Dec;29(17):1047-1053. doi: 10.1016/j.purol.2019.08.278. Epub 2019 Sep 17.
The objective of this study was to assess the effectiveness and the complications rate following continent cutaneous channels (CCC) procedures, at short and medium term follow-up (FU).
MATERIALS & METHODS: A continuous retrospective case series (2008-2018): all patients who have undergone a CCC for neurogenic bladder were included in our department. The primary outcome was the effectiveness of CCC defined by the status of catheterizability (by the patient or a care-giver), continence of the tube, and absence of reintervention at 3 and 12 months FU. The secondary outcome was the prevalence of postoperative complications at 3 and 12 months FU.
Fifty-three patients were included during the study period in our department. Median follow up was 3,3 years (1.5-6.1). The overall effectiveness of CCC was 67.9% (n=36/53) at 3 months FU and 45,3% (n=24) at 12 months FU. The global rate of complications was 60.4% (n=32/53) at 3 months, and 73.6% (n=39/73) at 12 months FU. The statistical analysis showed no statistical differences on efficacy and complications in the different subgroups of CCC.
In the current series, the effectiveness and the complications rates following CCC were comparable across the procedure types.
本研究的目的是评估在短期和中期随访（FU）中，可控性皮肤通道（CCC）手术的有效性和并发症发生率。
连续回顾性病例系列研究（2008 - 2018年）：我科纳入了所有接受CCC治疗神经源性膀胱的患者。主要结局是CCC的有效性，通过可导尿状态（由患者或护理人员操作）、管道的可控性以及在3个月和12个月随访时无需再次干预来定义。次要结局是在3个月和12个月随访时术后并发症的发生率。
在研究期间，我科共纳入53例患者。中位随访时间为3.3年（1.5 - 6.1年）。在3个月随访时，CCC的总体有效性为67.9%（n = 36/53），在12个月随访时为45.3%（n = 24）。并发症总发生率在3个月时为60.4%（n = 32/53），在12个月随访时为73.6%（n = 39/73）。统计分析显示，在CCC的不同亚组中，疗效和并发症方面无统计学差异。
在本系列研究中，不同手术类型的CCC术后有效性和并发症发生率相当。
4级。
